RHI Magnesita stock: fair value
RHIM.VIThe fair value of RHI Magnesita under our model is $69.15, the price is 46% below.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $49.39 and expensive above $115.25 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $89.45 (cash-flow model) and $48.85 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 11.7%. At 12.7% the fair value would be $64.29, at 10.7% it would be $75.23.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (19.5).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 2.6%. Discounted at 11.7% (government bond yield 2.6% plus beta 2 times a risk premium of 4.6%); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $89.45 per share: free cash flow for the next ten years, each year discounted to today at 11.7%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 11.7%) |
|---|---|---|---|---|
| 2026 | $227.93M | extrapolated at 37.0% | 0.8949 | $203.98M |
| 2027 | $288.67M | extrapolated at 26.7% | 0.8009 | $231.2M |
| 2028 | $344.74M | extrapolated at 19.4% | 0.7168 | $247.1M |
| 2029 | $394.26M | extrapolated at 14.4% | 0.6415 | $252.9M |
| 2030 | $436.93M | extrapolated at 10.8% | 0.5741 | $250.83M |
| 2031 | $473.39M | extrapolated at 8.3% | 0.5137 | $243.2M |
| 2032 | $504.68M | extrapolated at 6.6% | 0.4598 | $232.03M |
| 2033 | $531.9M | extrapolated at 5.4% | 0.4115 | $218.86M |
| 2034 | $556.07M | extrapolated at 4.5% | 0.3682 | $204.76M |
| 2035 | $578.03M | extrapolated at 4.0% | 0.3295 | $190.49M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $2.28B |
| Terminal value: cash flow 2035 × (1 + 2.6%) / (11.7% − 2.6%) | $6.46B |
| Present value of terminal value (× 0.3295) | $2.13B |
| Equity value (sum plus present value of terminal value) | $4.4B |
| Shares (diluted) | 49.23M |
| Value per share (equity value divided by shares) | $89.45 |
| Earnings per share, last twelve months | $2.50 |
| × 19.5 (industry P/E) | $48.85 |
| Fair value (average of both parts) | $69.15 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Apr 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.